Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): A randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults
- 31 May 2007
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 29 (5), 814-822
- https://doi.org/10.1016/j.clinthera.2007.05.001
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A review of the second-generation antihistamine ebastine for the treatment of allergic disordersExpert Opinion on Pharmacotherapy, 2004
- Efficacy and Safety of Ebastine 20 mg Compared to Loratadine 10 mg Once Daily in the Treatment of Seasonal Allergic Rhinitis: A Randomized, Double-Blind, Placebo-Controlled StudyInternational Archives of Allergy and Immunology, 2004
- Efficacy of ebastine in the control of nasal congestion associated with allergic rhinitisMethods and Findings in Experimental and Clinical Pharmacology, 2003
- A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Ebastine 20 mg Once Daily Given with and without Food in the Treatment of Seasonal Allergic RhinitisThe Journal of Clinical Pharmacology, 2002
- Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 2000
- A 12‐week, placebo‐controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitisAllergy, 1999
- Comparison of Ebastine to Cetirizine in Seasonal Allergic Rhinitis in AdultsAnnals of Allergy, Asthma & Immunology, 1996
- Double-Blind Multicentre Comparative Study of Ebastine, Terfenadine and Placebo in the Treatment of Chronic Idiopathic Urticaria in AdultsDrugs, 1996
- Clinical Studies of the Efficacy and Tolerability of Ebastine 10 or 20mg Once Daily in the Treatment of Seasonal Allergic Rhinitis in the USDrugs, 1996
- Ebastine in chronic urticaria: A double-blind placebo-controlled studyJournal of Dermatological Treatment, 1991